Rescheduling
Rescheduling · page 4
- Uncategorized
What Does Trump’s America Mean for Cannabis?
As the most consequential US election in recent history comes to close after a long and turbulent campaign, the dust is beginning to settle on the prospective outlook for cannabis under the new administration.
- Uncategorized
Calls for Treasury to Update Tax Guidelines for Cannabis Businesses as Rescheduling Decision Looms
Ahead of the upcoming public hearing on cannabis rescheduling in the US, the American Institute of Certified Public Accountants (AICPA) has called on the Treasury Department to update tax guidelines for cannabis businesses.
- Uncategorized
The Hidden Costs of Cannabis Legalization: What About the Patients?
Writing for Business of Cannabis, Deborah Tharp, a cannabis-focused political consultant, campaign manager and legal researcher for Nugg and NuggMD, explains why it’s more crucial than ever not to overlook the stark differences between medical and recreational cannabis use.
- Uncategorized
‘I Have Felt For a Long Time We Need to Legalize It’ – Kamala Harris Publicly Endorses Cannabis Legalization
Vice President Kamala Harris has reaffirmed her support for legalizing cannabis, discussing the issue publicly for the first time since becoming the Democratic presidential nominee.
- Uncategorized
Biden Concedes Rescheduling Is Not a Done Deal as Investor Sentiment Wanes
US President Joe Biden has conceded that cannabis rescheduling is not yet a done deal, and is now almost certain to take place after his term is up.
- Uncategorized
Trump Endorses Rescheduling & Safer Banking Sending Cannabis Stocks Flying
As Vice President Kamala Harris’s poll lead begins to dwindle, former President Donald Trump has taken to espousing uncharacteristically liberal policies to win over potential voters.
- Uncategorized
Rescheduling Delay Sends Cannabis Stocks Into Tailspin
News that the US Drug Enforcement Administration (DEA) is set to host a public administrative hearing on cannabis rescheduling has immediately impacted cannabis stocks.
- Uncategorized
HHS Publishes Long-Awaited Report Into Cannabis Research Calling for Simplification of Process
The US Department of Health and Human Services (HHS) has officially completed its report into the state of cannabis research in the country, six months overdue.
- Data & Analysis
Over 90% of Cannabis Rescheduling Comments Are in Favour of the Move, With the Majority Calling for Further Reform
Analysis of the 42,000 public comments submitted to the Drug Enforcement Administration (DEA) regarding cannabis rescheduling shows ‘overwhelming support’ for reform.
- Uncategorized
Landmark Ruling May Delay US Cannabis Rescheduling Efforts
The planned rescheduling of cannabis in the US could now take far longer than initially expected following a landmark Supreme Court decision last week.
- Uncategorized
Cannabis Rescheduling Sparks Over 30,000 Public Comments Ahead of Deadline
The US Drug Enforcement Administration (DEA) has recieved over 30,000 comments on the planned cannabis rescheduling since opening up for public consultation in May.
- Uncategorized
Cannabis Rescheduling Dealt Blow as House Committee Passes Bill Aimed at Blocking Progress
The landmark US cannabis rescheduling project was dealt a major blow this week, as a controversial spending bill aimed at blocking the bill was passed by a key House Committee.
